Introduction
A group of genetic conditions leading to tumours arising from nerve tissue
- Depending on the manifestation (1,2,3) will have different aetiologies and manifestations.
- NF1 is most common, ~1 in every 2500, 3000 people in Australia
- NF2 is rare, with ~1 in every 25,000 to 40,000 people being afflicted.
- Schwannomatosis is rare, typically appearing in people over 30 years of age.
- ~15% inherited and ~1 in 40,000 people
- All affect populations regardless of ethnicity or gender, and many features to not appear until later childhood or early adulthood, and variable expression and severity

Dead Giveaways
Neurofibromatosis 1:
Due to a defect in the NF1 gene on chromosome 17q11 damaging neurofibromin 1
For a diagnosis to be made, it must possess 2 of the 7 following criteria:
Six or more cafe-au-lait spots
>5mm in pre-pubertal children
>15mm in post-pubertal children

The cafe-au-lait spots
2 or more Lisch Nodules of the iris.
Seen typically from the 2nd or 3rd decade as translucent or pigmented nodules (<3mm)

The Lisch Nodule Dots
2 or more neurofibromas of any type, or one plexiform neurofibroma
Neurofibromas appear at puberty as pedunculated and flabby nodules
Increases number with life, often widely distributed, internally and externally
Cutaneous neurofibromas are soft skin-coloured to purple nodules that may become pedunculated as they grow
Usually develop in late adolescence and found in vast majority of Px with NF1
Can have few lesions to thousands. They are benign with no risk of malignancy, but are very uncomfortable and have cosmetic disfigurement

Solitary neurofibroma
Plexiform neurofibromas present in 30% of NF1, affecting the more complex nerve plexuses and can lead to eyelid neurofibromas which can cause mechanical ptosis.

Associated with glaucoma
Neurofibromas infiltrate the anterior angle, leading to secondary angle closure, since the neurofibromas cause ciliary body and choroidal thickening, along with ectropion uveae and endothelialisation of angle
Fibrovascularisation can cause synechial angle closure and neovascular glaucoma.
Developmental angle abnormalities
Freckling in the axilla or groin
Optic pathway glioma
Represents ~70% of all ON sheath tumours; can arise within optic pathways, ON, optic tract and brainstem.
~15-20% of children with NF-1 will develop an optic pathway glioma
A benign slow growing tumour.
~30% of optic pathway glioma Px have NF1 and bilateral optic pathway gliomas are diagnostic for NF1

Children aged <6y with NF1 are most at risk
Distinct bony lesion
Bone defect in orbital wall (sphenoid), or bowing of long bones in legs. etc.
A 1st degree relative with NF1 with above criteria
Choroidal Nodules
Neurofibromatosis 2:
Associated with certain clinical features:
hearing loss/tinitius/imbalance
Bilateral acoustic neuromas (schwannomas) from schwann cells around nerves)
1st degree relative with NF2 with unilateral acoustic neuroma + any 2 of the following:
Meningioma
Glioma
Schwannomas of other nerves
Early onset cataracts
Combined hamartoma of retina/RPE
Ophthalmic Features:
Cataracts before age 30
Fundus lesions like hamartomas, perifoveal epiretinal membrane
Ocular motor problems (~10%)
Others like optic pathway glioma, ON sheath meningioma
Schwannomatosis (NF3):
Benign tumour composed of Schwann cells.
Unlike NF2, doesn't develop vestibular tumours
Growth of multiple Schwannomas throughout body causes chronic intense pain
Can have unilateral vestibular schwannomas sometimes, but not bilateral (NF2)
diagnostic features
Optic Pathway Glioma Signs/Symptoms:
Proptosis
Vision loss
Optic atrophy
Optic nerve oedema
Slow vision loss that can remain stable in ~80% of patients.
VF changes can also manifest
NF3 Symptoms/Signs:
Extreme intense pain; tumours growing and presses on nerves or nearby tissue
Numbness, tingling or weakness in fingers and toes
Vision changes
Headaches
Prognosis
Life expectancy greatly reduced for Px with NF1 and 2
Principal causes of early death with NF1
Complication of systemic hypertension, expansive growth of benign intracranial tumours
Several types of cancer including neurofibrosarcoma, other sarcomas, leukemias, and lymphomas occur with increase frequency in NF1
In NF2, the main cause of death comes from the expansion of the CNS tumour.
Unilateral or bilateral blindness: usually optic pathway glioma; occasionally related to intracranial vestibular schwannoma